The Penicillin Allergy Verification and Evaluation (PAVE) Act, introduced in September 2024, aims to improve healthcare for seniors by including penicillin allergy verification and evaluation in Medicare's initial preventive physical examination and annual wellness visits. This involves identifying individuals who report a penicillin allergy, assessing the validity of these reports, educating them on the implications of such a label, and referring them to specialists if necessary. The goal is to ensure accurate medical records and appropriate antibiotic use, as many self-reported penicillin allergies are found to be inaccurate.
H.R. 9778 was introduced in the 119th Congress by Dan Goldman (Democrat) and is currently listed as “Introduced”. It is classified under the Law policy area, one of 60 bills in that area we track this Congress.
Dan Goldman is the sponsor of 17 bills in our database this Congress, so H.R. 9778 is part of a broader legislative agenda rather than a one-off proposal.
Senate lobbying disclosures list 15 organizations lobbying on this bill’s issue area.
Our conflict-of-interest analysis rates H.R. 9778 2/10 (low risk), higher than 76% of analyzed bills; the average in Law is 2.1/10.
Supporters of the PAVE Act highlight its potential to enhance patient safety and antibiotic stewardship. By verifying penicillin allergies, the bill could reduce unnecessary use of alternative antibiotics, which are often less effective and more expensive. This initiative is seen as a proactive step in improving healthcare outcomes for seniors and optimizing Medicare services.
Critics of the PAVE Act express concerns about the feasibility and cost of implementing widespread allergy verification within Medicare. They argue that the additional procedures may strain healthcare resources and question whether the benefits justify the expenses. Some also worry about the potential for increased patient anxiety and the risk of adverse reactions during the verification process.
The analysis of H.R. 9778, sponsored by Dan Goldman, reveals no direct industry overlaps between the bill's subject matter and the sponsor's top donor industries. The bill aims to create a right of public access to certain court records, which does not appear to directly benefit any of Goldman's top donors. The lobbying activity in this policy area includes significant contributions from various organizations, such as the American College of Emergency Physicians, which contributed $498,299. However, this organization does not have a direct correlation with the bill's intent, suggesting that the financial interests of these groups are unlikely to influence the legislation. Overall, the lack of overlapping interests indicates a low risk of conflict of interest.
Organizations that lobbied on issues related to this bill's policy area.
| Client | Lobbying Firm | Amount |
|---|---|---|
| AMERICAN COLLEGE OF EMERGENCY PHYSICIANS | AMERICAN COLLEGE OF EMERGENCY PHYSICIANS | $498,299 |
| TRUST FOR PUBLIC LAND | THE TRUST FOR PUBLIC LAND | $150,000 |
| COLLIER COLLECTIVE, LLC | MCCOLL STRATEGIES LLC | $40,000 |
| HART HEALTH STRATEGIES | TIM YEHL, LLC | $40,000 |
| PANO AI | PANO AI | $40,000 |
| ALLIANCE FOR AUTOMOTIVE INNOVATION | TIM YEHL, LLC | $30,000 |
| BSA, THE SOFTWARE ALLIANCE | TIM YEHL, LLC | $20,000 |
| PSEG SERVICES CORPORATION | TIM YEHL, LLC | $20,000 |
| COUNTY OF NAPA | PARAGON GOVERNMENT RELATIONS | $15,000 |
| LAKE COUNTY | PARAGON GOVERNMENT RELATIONS | $15,000 |
| NEVADA COUNTY | PARAGON GOVERNMENT RELATIONS | $15,000 |
| HUMBOLDT COUNTY | PARAGON GOVERNMENT RELATIONS | $15,000 |
| NATIONAL ASSOCIATION OF COUNTY HUMAN SERVICES ADMINISTRATORS | PARAGON GOVERNMENT RELATIONS | $10,000 |
| NATIONAL CHILD SUPPORT ENFORCEMENT ASSOCIATION | PARAGON GOVERNMENT RELATIONS | $10,000 |
| CLARK COUNTY | PARAGON GOVERNMENT RELATIONS | undisclosed |
Source: Senate Lobbying Disclosure Act (LDA) filings, 2026
Top industries funding Dan Goldman, ranked by total contributions.
Source: OpenSecrets.org (Center for Responsive Politics)
What does H.R. 9778 do?
The Penicillin Allergy Verification and Evaluation (PAVE) Act, introduced in September 2024, aims to improve healthcare for seniors by including penicillin allergy verification and evaluation in Medicare's initial preventive physical examination and annual wellness visits. This involves identifying individuals who report a penicillin allergy, assessing the validity of these reports, educating…
Has H.R. 9778 received a floor vote?
No roll-call vote on H.R. 9778 is recorded in our database yet. Its current status is “Introduced”.
Does H.R. 9778 have a conflict of interest?
Our conflict-of-interest analysis rates H.R. 9778 2/10 (low risk), higher than 76% of analyzed bills; the average in Law is 2.1/10. This score reflects overlap between the sponsor’s campaign funding, lobbying activity, and the industries the bill affects. It is a transparency indicator, not an accusation.
What is the status of H.R. 9778?
H.R. 9778 is currently “Introduced” as of our last update on July 22, 2026.
Who sponsored H.R. 9778?
H.R. 9778 was sponsored by Dan Goldman (Democrat).
